Mark Fishman is an American cardiologist, a professor in the Harvard Department of Stem Cell and Regenerative Biology and Chief of the Pathways Clinical Service service at the MGH for patients with complex medical disorders. A researcher and clinician in cardiology, he is the previous president of the Novartis Institutes for BioMedical Research (NIBR), the main research arm of

Novartis Pharmaceuticals Novartis AG is a Swiss-American multinational corporation, multinational pharmaceutical company, pharmaceutical corporation based in Basel, Switzerland and Cambridge, Massachusetts, United States (global research).name="novartis.com">https://w ...

. Fishman was appointed president of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort. He is the author of over 100 publications and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.

Education

*B.A.

Yale College Yale College is the undergraduate college of Yale University. Founded in 1701, it is the original school of the university. Although other Yale schools were founded as early as 1810, all of Yale was officially known as Yale College until 1887, ...

, 1972 *M.D.

Harvard Medical School Harvard Medical School (HMS) is the graduate medical school of Harvard University and is located in the Longwood Medical Area of Boston, Massachusetts. Founded in 1782, HMS is one of the oldest medical schools in the United States and is consi ...

, 1976

Career

He was previously a professor of medicine at

, chief of cardiology at

Massachusetts General Hospital Massachusetts General Hospital (Mass General or MGH) is the original and largest teaching hospital of Harvard Medical School located in the West End neighborhood of Boston, Massachusetts. It is the third oldest general hospital in the United Stat ...

, and director of the Cardiovascular Research Center at

. He is a fellow of the National Academy of Arts and Sciences and a member of the National Academy of Sciences, Institute of Medicine. After being the head of Novartis for 13 years, he decided to retire in 2016 and became professor at Harvard and Chief at MGH

References

External links

Novartis Institutes for BioMedical Research Official Homepage

Novartis Institutes for BioMedical Research Official Homepage

Mark Fishman on changing the grammar of drug discovery
{{DEFAULTSORT:Fishman, Mark Living people American medical researchers American cardiologists Businesspeople in the pharmaceutical industry American business executives Year of birth missing (living people) Yale College alumni Harvard Medical School alumni Harvard Medical School faculty Fellows of the American College of Cardiology Members of the National Academy of Medicine